128 related articles for article (PubMed ID: 16174106)
1. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity.
Aldwell FE; Baird MA; Fitzpatrick CE; McLellan AD; Cross ML; Lambeth MR; Buchan GS
Immunol Cell Biol; 2005 Oct; 83(5):549-53. PubMed ID: 16174106
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG).
Dorer DE; Czepluch W; Lambeth MR; Dunn AC; Reitinger C; Aldwell FE; McLellan AD
Cell Microbiol; 2007 Feb; 9(2):544-53. PubMed ID: 17018037
[TBL] [Abstract][Full Text] [Related]
4. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
[TBL] [Abstract][Full Text] [Related]
5. Aerosol immunization by alginate coated mycobacterium (BCG/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice.
Nagpal PS; Kesarwani A; Sahu P; Upadhyay P
BMC Infect Dis; 2019 Jul; 19(1):568. PubMed ID: 31262260
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
Lagranderie MR; Balazuc AM; Deriaud E; Leclerc CD; Gheorghiu M
Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324
[TBL] [Abstract][Full Text] [Related]
7. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.
Aldwell FE; Tucker IG; de Lisle GW; Buddle BM
Infect Immun; 2003 Jan; 71(1):101-8. PubMed ID: 12496154
[TBL] [Abstract][Full Text] [Related]
9. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
10. Oral vaccination of badgers (Meles meles) against tuberculosis: comparison of the protection generated by BCG vaccine strains Pasteur and Danish.
Murphy D; Costello E; Aldwell FE; Lesellier S; Chambers MA; Fitzsimons T; Corner LA; Gormley E
Vet J; 2014 Jun; 200(3):362-7. PubMed ID: 24792450
[TBL] [Abstract][Full Text] [Related]
11. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
[TBL] [Abstract][Full Text] [Related]
12. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
[TBL] [Abstract][Full Text] [Related]
13. Detection of live M. bovis BCG in tissues and IFN-γ responses in European badgers (Meles meles) vaccinated by oropharyngeal instillation or directly in the ileum.
Lesellier S; Boschiroli ML; Barrat J; Wanke C; Salguero FJ; Garcia-Jimenez WL; Nunez A; Godinho A; Spiropoulos J; Palmer S; Dave D; Anderson P; Boucher JM; de Cruz K; Henault S; Michelet L; Gowtage S; Williams GA; Nadian AK; Monchâtre-Leroy E; Boué F; Chambers MA; Richomme C
BMC Vet Res; 2019 Dec; 15(1):445. PubMed ID: 31810466
[TBL] [Abstract][Full Text] [Related]
14. Murine cytokine responses following multiple oral immunizations using lipid-formulated mycobacterial antigens.
Cross ML; Lambeth MR; Aldwell FE
Immunol Cell Biol; 2008 Feb; 86(2):214-7. PubMed ID: 17998917
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Effect of reducing or eliminating BCG load on cell-mediated immunity.
Cross ML; Lambeth MR; Coughlan Y; Aldwell FE
Vaccine; 2007 Jan; 25(7):1297-303. PubMed ID: 17067728
[TBL] [Abstract][Full Text] [Related]
16. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
19. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
20. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
